RhumbLine Advisers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136M Sell
1,590,058
-23,887
-1% -$2.13M 0.12% 151
2025
Q4
$128M Sell
1,613,945
-47,296
-3% -$3.71M 0.1% 155
2025
Q3
$133M Sell
1,661,241
-6,667
-0.4% -$569K 0.11% 154
2025
Q2
$152M Sell
1,667,908
-103,513
-6% -$9.45M 0.13% 132
2025
Q1
$166M Sell
1,771,421
-74,823
-4% -$6.7M 0.16% 111
2024
Q4
$168M Buy
1,846,244
+4,747
+0.3% +$453K 0.15% 106
2024
Q3
$191M Buy
1,841,497
+28,063
+2% +$2.86M 0.17% 100
2024
Q2
$176M Buy
1,813,434
+61,811
+4% +$5.7M 0.17% 104
2024
Q1
$158M Buy
1,751,623
+61,333
+4% +$5.2M 0.15% 115
2023
Q4
$135M Sell
1,690,290
-11,209
-0.7% -$843K 0.14% 121
2023
Q3
$121M Buy
1,701,499
+30,777
+2% +$2.3M 0.14% 125
2023
Q2
$129M Sell
1,670,722
-31,097
-2% -$2.41M 0.14% 121
2023
Q1
$128M Buy
1,701,819
+55,141
+3% +$4.1M 0.16% 116
2022
Q4
$130M Buy
1,646,678
+58,161
+4% +$4.36M 0.17% 110
2022
Q3
$112M Sell
1,588,517
-33,309
-2% -$2.61M 0.17% 110
2022
Q2
$130M Buy
1,621,826
+10,437
+0.6% +$816K 0.19% 94
2022
Q1
$122M Buy
1,611,389
+4,086
+0.3% +$324K 0.16% 114
2021
Q4
$137M Buy
1,607,303
+3,410
+0.2% +$266K 0.17% 107
2021
Q3
$121M Sell
1,603,893
-3,695
-0.2% -$293K 0.16% 110
2021
Q2
$131M Sell
1,607,588
-82,292
-5% -$6.73M 0.17% 106
2021
Q1
$133M Sell
1,689,880
-44,210
-3% -$3.47M 0.18% 103
2020
Q4
$148M Buy
1,734,090
+1,136
+0.1% +$93.9K 0.2% 93
2020
Q3
$134M Sell
1,732,954
-4,157
-0.2% -$317K 0.21% 89
2020
Q2
$127M Buy
1,737,111
+51,254
+3% +$3.64M 0.21% 86
2020
Q1
$112M Buy
1,685,857
+7,958
+0.5% +$561K 0.23% 84
2019
Q4
$116M Buy
1,677,899
+33,670
+2% +$2.3M 0.19% 102
2019
Q3
$121M Buy
1,644,229
+60,575
+4% +$4.39M 0.22% 84
2019
Q2
$114M Sell
1,583,654
-39,007
-2% -$2.77M 0.21% 85
2019
Q1
$111M Sell
1,622,661
-8,907
-0.5% -$575K 0.22% 88
2018
Q4
$97.1M Buy
1,631,568
+8,638
+0.5% +$540K 0.21% 89
2018
Q3
$109M Sell
1,622,930
-34,793
-2% -$2.32M 0.21% 92
2018
Q2
$107M Buy
1,657,723
+8,282
+0.5% +$542K 0.22% 90
2018
Q1
$118M Sell
1,649,441
-42,691
-3% -$3.07M 0.25% 79
2017
Q4
$128M Buy
1,692,132
+24,333
+1% +$1.78M 0.26% 73
2017
Q3
$121M Buy
1,667,799
+13,574
+0.8% +$978K 0.26% 71
2017
Q2
$123M Sell
1,654,225
-12,319
-0.7% -$915K 0.28% 68
2017
Q1
$122M Buy
1,666,544
+76,498
+5% +$5.35M 0.28% 65
2016
Q4
$104M Buy
1,590,046
+144,423
+10% +$9.9M 0.26% 71
2016
Q3
$107M Buy
1,445,623
+47,265
+3% +$3.49M 0.3% 64
2016
Q2
$102M Buy
1,398,358
+44,863
+3% +$3.19M 0.3% 65
2016
Q1
$95.6M Sell
1,353,495
-909
-0.1% -$60.5K 0.3% 62
2015
Q4
$90.2M Sell
1,354,404
-8,429
-0.6% -$561K 0.29% 66
2015
Q3
$86.5M Buy
1,362,833
+70,626
+5% +$4.61M 0.29% 66
2015
Q2
$84.5M Sell
1,292,207
-221,696
-15% -$15M 0.27% 70
2015
Q1
$105M Sell
1,513,903
-4,080
-0.3% -$282K 0.3% 69
2014
Q4
$105M Sell
1,517,983
-37,532
-2% -$2.53M 0.31% 70
2014
Q3
$101M Sell
1,555,515
-34,520
-2% -$2.28M 0.3% 65
2014
Q2
$108M Sell
1,590,035
-74,649
-4% -$5M 0.32% 62
2014
Q1
$108M Sell
1,664,684
-16,040
-1% -$1.01M 0.32% 60
2013
Q4
$110M Sell
1,680,724
-64,705
-4% -$4.14M 0.32% 61
2013
Q3
$104M Sell
1,745,429
-99,455
-5% -$5.89M 0.32% 63
2013
Q2
$106M Buy
+1,844,884
New +$110M 0.34% 58

Other funds holding CL

RhumbLine Advisers's CL Position: Q1 2026 in Review

RhumbLine Advisers reduced its Colgate-Palmolive (CL) stake by 1.5% in Q1 2026, selling an estimated $2.13M and leaving 1,590,058 shares worth $136M. The position accounts for 0.12% of the portfolio, ranked #151.

RhumbLine Advisers first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $191M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • RhumbLine Advisers held 1,590,058 shares of Colgate-Palmolive worth $136M as of Q1 2026.
  • RhumbLine Advisers sold 23,887 Colgate-Palmolive shares in Q1 2026, an estimated $2.13M.
  • Colgate-Palmolive made up 0.12% of RhumbLine Advisers's portfolio in Q1 2026, its #151 holding.
  • RhumbLine Advisers first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • RhumbLine Advisers's Colgate-Palmolive position peaked at $191M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.